Hezzell, M. J., Block, C. L., Laughlin, D. S., & Oyama, M. A. (2018). Effect of prespecified therapy escalation on plasma NT‐proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease. J Vet Intern Med.
Dyfyniad Arddull ChicagoHezzell, Melanie J., Chloë L. Block, Danielle S. Laughlin, and Mark A. Oyama. "Effect of Prespecified Therapy Escalation On Plasma NT‐proBNP Concentrations in Dogs With Stable Congestive Heart Failure Due to Myxomatous Mitral Valve Disease." J Vet Intern Med 2018.
Dyfyniad MLAHezzell, Melanie J., Chloë L. Block, Danielle S. Laughlin, and Mark A. Oyama. "Effect of Prespecified Therapy Escalation On Plasma NT‐proBNP Concentrations in Dogs With Stable Congestive Heart Failure Due to Myxomatous Mitral Valve Disease." J Vet Intern Med 2018.